AtriCure Receives FDA 510(k) Clearance For Isolator(TM) Synergy(TM) Bipolar Ablation System And Performs First Case

... AtriCure, Inc. (Nasdaq: ATRC), a medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today that it has received Food and Drug Administration 510(k) clearance for its Isolator(TM) Synergy(TM) Bipolar Ablation System for the ablation of soft tissue. The device is not yet cleared for the ablation of cardiac tissue. [click link for full article] ...